We added 6-aminonicotinamide (6AN), a G6PD inhibitor, and 2,5-dichloro-N-(5-chloro-2-benzoxazolyl)-benzenesulfonamide, an FBP1 inhibitor (FBPi) in this in vitro granuloma model (Figure 6C). The gene discussed is FBP1; the disease is Granuloma.